Beijing BIOOCUS Biotech Ltd. is proud to introduce its groundbreaking intra-tumoral lymphocyte therapy, which represents a promising advancement in the treatment of cancer. Our innovative approach harnesses the power of the body's own immune system to target and eliminate cancerous cells within tumors, Through extensive research and development, our team at BIOOCUS Biotech has developed a proprietary method for isolating and activating tumor-infiltrating lymphocytes (TILs), which are then re-infused into the tumor to directly attack cancer cells. This targeted approach has shown great potential in effectively treating various types of cancer, with minimal side effects and superior efficacy
Please feel free to give your inquiry in the form below We will reply you in 24 hours